Soy isoflavones improve sympathetic nervous system-driven non-alcoholic fatty liver disease through estrogen-like effects

Jing Yang, Yuhang Zhao, Zhengjie Ye, Zhiyi Liu, Lingling Chang, Xinran Wang, Yuandong Qiao, Liquan Tong and Yonggang Cao

Food Funct., 2025
DOI: 10.1039/D5FO01459J

Investigating the mechanism of Jiawei Xiaoyao San in treating metabolic associated fatty liver disease (MAFLD) based on the ileal microbiota-bile acid-FXR axis

Taotao Wei, Gaozhong Dai, Tianye Liu and Yaozhou Tian

Advances in Integrative Medicine, 2025, 12, 100567
DOI: 10.1016/j.aimed.2025.100567

Sulforaphane: A nutraceutical against diabetes-related complications

Sinenhlanhla X.H. Mthembu, Sithandiwe E. Mazibuko-Mbeje, Marakiya T. Moetlediwa, Ndivhuwo Muvhulawa, Sonia Silvestri, Patrick Orlando, Bongani B. Nkambule, Christo J.F. Muller, Duduzile Ndwandwe, Albertus K. Basson, Luca Tiano and Phiwayinkosi V. Dludla

Pharmacological Research, 2023, 196, 106918
DOI: 10.1016/j.phrs.2023.106918

Caffeic acid and chlorogenic acid mediate the ADPN-AMPK-PPARα pathway to improve fatty liver and production performance in laying hens

Wenjie Tian, Gerard Bryan Gonzales, Hao Wang, Youyou Yang, Chaohua Tang, Qingyu Zhao, Junmin Zhang, Huiyan Zhang and Yuchang Qin

J Animal Sci Biotechnol, 2025, 16
DOI: 10.1186/s40104-025-01175-z

FXR overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in alcoholic liver disease

Lin Li, Lina Kong, Shuai Xu, Changyuan Wang, Jiangning Gu, Haifeng Luo and Qiang Meng

Hepatol Int, 2024, 18, 188
DOI: 10.1007/s12072-023-10621-x

Cholesterol Oxidation Products: Potential Adverse Effect and Prevention of Their Production in Foods

Chuanling Deng, Mingxuan Li, Yang Liu, Chi Yan, Zouyan He, Zhen-Yu Chen and Hanyue Zhu

J. Agric. Food Chem., 2023, 71, 18645
DOI: 10.1021/acs.jafc.3c05158

Screening of bile salt hydrolase-producing lactic acid bacteria and evaluation of cholesterol-lowering activity in vitro

Chenglong Lv, Xinyi Pang, Jing Sun, Xiangfei Li and Yingjian Lu

Food Bioscience, 2024, 62, 105338
DOI: 10.1016/j.fbio.2024.105338

Broccoli leaf crude extract: a promising remedy for metabolic associated fatty liver diseases through lipid reduction, antioxidation, and anti‐inflammation

Yuhong Huang, Mengxue Sun, Liying Ni, Bin Wang, Ming Zhang, Guiguang Cheng, Maoyu Wu and Chao Ma

J Sci Food Agric, 2025, 105, 7210
DOI: 10.1002/jsfa.14423

Protective role of sulforaphane in lipid metabolism-related diseases

Lingfeng Zhao, Jiahuan Li, Yiping Dang, David Fisher, Nguyen Thi Thu Hien, Erkin Musabaev, Khrystyna Pronyuk and Lei Zhao

Mol Biol Rep, 2025, 52
DOI: 10.1007/s11033-025-10358-w

Involvement of Bile Acid Metabolism and Gut Microbiota in the Amelioration of Experimental Metabolism-Associated Fatty Liver Disease by Nobiletin

Hongling Xu, Mingming Yuan, Kailin Niu, Wei Yang, Maoyuan Jiang, Lei Zhang and Jing Zhou

Molecules, 2024, 29, 976
DOI: 10.3390/molecules29050976

Therapeutic potential of sulforaphane in liver diseases: a review

Liang Yan and Yachun Yan

Front. Pharmacol., 2023, 14
DOI: 10.3389/fphar.2023.1256029

Innovative treatments for obesity and NAFLD: A bibliometric study on antioxidants, herbs, phytochemicals, and natural compounds

Salvatore Pezzino, Maria Sofia, Chiara Mazzone, Giorgia Litrico, Luigi Piero Greco, Luisa Gallo, Gaetano La Greca and Saverio Latteri

Heliyon, 2024, 10, e35498
DOI: 10.1016/j.heliyon.2024.e35498

Oral Sulforaphane Intervention Protects Against Diabetic Cardiomyopathy in db/db Mice: Focus on Cardiac Lipotoxicity and Substrate Metabolism

Pan Wang, Ziling Wang, Xinyuan Jin, Mengdi Zhang, Mengfan Shen and Dan Li

Antioxidants, 2025, 14, 603
DOI: 10.3390/antiox14050603

Sulforaphane Improves Liver Metabolism and Gut Microbiota in Circadian Rhythm Disorder Mice Models Fed With High‐Fat Diets

Canxia He, Mengyuan Chen, Xiaoxin Jiang, Jingyi Ren, Srikar Varma Ganapathiraju, Peng Lei, Haitao Yang, Prabh Roohan Pannu, Yun Zhao and Xiaohong Zhang

Molecular Nutrition Food Res, 2024, 68
DOI: 10.1002/mnfr.202400535